$CANB
Can B Corp Stock $canb

$canb Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224046837 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$15.27K	$419.0K
YoY Change		-96.36%	-85.49%
Cost Of Revenue		$415.8K	$1.236M
YoY Change		-66.35%	20.06%
Gross Profit		-$400.5K	-$816.7K
YoY Change		-50.95%	-143.93%
Gross Profit Margin		-2623.27%	-194.93%
Selling, General & Admin		$2.432M	$2.762M
YoY Change		-11.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$351.2K
YoY Change			0.49%
% of Gross Profit
Operating Expenses		$2.432M	$2.762M
YoY Change		-11.92%	-68.21%
Operating Profit		-$2.833M	-$3.578M
YoY Change		-20.83%	-47.59%
Interest Expense			$585.4K
YoY Change			252.68%
% of Operating Profit
Other Income/Expense, Net		-$429.7K	-$587.2K
YoY Change		-26.83%	789.53%
Pretax Income		-$3.263M	-$4.165M
YoY Change		-21.67%	-39.58%
Income Tax
% Of Pretax Income
Net Earnings		-$3.263M	-$4.165M
YoY Change		-21.67%	-39.58%
Net Earnings / Revenue		-21367.56%	-994.23%
Basic Earnings Per Share		-$0.05	-$0.36
Diluted Earnings Per Share		-$0.05	-$0.36
COMMON SHARES
Basic Shares Outstanding	75.84M shares	63.66M shares	9.614M shares
Diluted Shares Outstanding		65.44M shares	11.59M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$31.32K
YoY Change		-9.14%
Cash & Equivalents	$7.879K	$31.32K
Short-Term Investments
Other Short-Term Assets		$29.14K
YoY Change		61.8%
Inventory	$155.9K	$959.7K
Prepaid Expenses
Receivables	$1.420M	$6.613M
Other Receivables		$0.00
Total Short-Term Assets	$1.594M	$7.633M
YoY Change	-79.12%	-18.38%
LONG-TERM ASSETS
Property, Plant & Equipment		$4.453M
YoY Change		-22.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.56K	$13.14K
YoY Change	26.0%	0.0%
Total Long-Term Assets	$262.3K	$5.443M
YoY Change	-95.18%	-26.13%
TOTAL ASSETS
Total Short-Term Assets	$1.594M	$7.633M
Total Long-Term Assets	$262.3K	$5.443M
Total Assets	$1.856M	$13.08M
YoY Change	-85.8%	-21.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.631M	$4.047M
YoY Change	-35.0%	30.51%
Accrued Expenses		$595.9K
YoY Change		228.0%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$7.842M
YoY Change		7.96%
Total Short-Term Liabilities	$11.64M	$12.86M
YoY Change	-9.43%	11.25%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change		-100.0%
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.64M	$12.86M
Total Long-Term Liabilities
Total Liabilities	$11.64M	$12.86M
YoY Change	-9.43%	5.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$113.9M	-$100.6M
YoY Change	13.23%	12.06%
Common Stock	$84.82M	$82.68M
YoY Change	2.59%	5.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$572.7K	$572.7K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$9.788M	$219.6K
YoY Change
Total Liabilities & Shareholders Equity	$1.856M	$13.08M
YoY Change	-85.8%	-21.79%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$3.263M	-$4.165M
YoY Change	-21.67%	-39.58%
Depreciation, Depletion And Amortization		$351.2K
YoY Change		0.49%
Cash From Operating Activities		-$206.6K
YoY Change		-80.58%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		114.5K
YoY Change		-88.25%
NET CHANGE
Cash From Operating Activities		-206.6K
Cash From Investing Activities		0.000
Cash From Financing Activities		114.5K
Net Change In Cash		-92.12K
YoY Change		2.84%
FREE CASH FLOW
Cash From Operating Activities		-$206.6K
Capital Expenditures		$0.00
Free Cash Flow		-$206.6K
YoY Change		-80.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001509957
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity Registrant Name EntityRegistrantName	Can B Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3624118
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 120
	dei	Entity Address City Or Town EntityAddressCityOrTown	Hicksville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11801
	dei	City Area Code CityAreaCode	516
	dei	Local Phone Number LocalPhoneNumber	595-9544
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75841988	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7879	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34006	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4774088	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2818395	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1419978	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3723344	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	155917	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1619542	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65435733	shares
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity File Number EntityFileNumber	000-55753
	dei	Entity Address Address Line1 EntityAddressAddressLine1	960 South Broadway
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10065	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4137	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	1593839	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5381029	usd
CY2024Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	245755	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	235418	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	95144	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4106283	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	295151	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16555	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13139	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	262310	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	4745135	usd
CY2024Q3	us-gaap	Assets Assets	1856149	usd
CY2023Q4	us-gaap	Assets Assets	10126164	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2694649	usd
	us-gaap	Gross Profit GrossProfit	-915794	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5918933	usd
	us-gaap	Operating Expenses OperatingExpenses	5918933	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1335799	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	68227	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1087104	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7921831	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	CANB	Stockbased Wages And Salaries StockbasedWagesAndSalaries		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	CANB	Contract Settlement ContractSettlement		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	CANB	Cancellation Of Debt CancellationOfDebt		usd
	CANB	Stockbased Consulting Expense StockbasedConsultingExpense		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	CANB	Issuance Of Common Stock For Contract Settlement IssuanceOfCommonStockForContractSettlement		usd
	CANB	Issuance Of Note Payable In Connection With Note Extension IssuanceOfNotePayableInConnectionWithNoteExtension		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	CANB	Debt Discount Associated With Convertible Note DebtDiscountAssociatedWithConvertibleNote		usd
	CANB	Issuance Of Common Stock Warrants And Commitment Shares In Connection With Convertible Promissory Note IssuanceOfCommonStockWarrantsAndCommitmentSharesInConnectionWithConvertiblePromissoryNote		usd
CY2024Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
	CANB	Issuance Of Warrant Liabilities IssuanceOfWarrantLiabilities		usd
CY2024Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
CY2024Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
CY2024Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross		usd
CY2024Q3	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross		usd
CY2024Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2024Q3	CANB	Medical Equipment MedicalEquipment		usd
CY2024Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross		usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2024Q3	CANB	Finite Lived Technology Ip And Patents FiniteLivedTechnologyIpAndPatents		usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q3	us-gaap	Share Price SharePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2630697	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1997643	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	457850	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	357243	usd
CY2024Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	8555243	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	9372714	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1766	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	254391	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11643790	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11983757	usd
CY2024Q3	us-gaap	Liabilities Liabilities	11643790	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11983757	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70122981	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70122981	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32753196	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32753196	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	84818600	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	82459880	usd
CY2024Q3	CANB	Common Stock Issuable No Par Value CommonStockIssuableNoParValue	0
CY2023Q4	CANB	Common Stock Issuable No Par Value CommonStockIssuableNoParValue	0
CY2024Q3	CANB	Common Stock Issuable Shares CommonStockIssuableShares	36248	shares
CY2023Q4	CANB	Common Stock Issuable Shares CommonStockIssuableShares	36248	shares
CY2024Q3	CANB	Common Stock Issuable Value CommonStockIssuableValue	119586	usd
CY2023Q4	CANB	Common Stock Issuable Value CommonStockIssuableValue	119586	usd
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	572678	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	572678	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11559910	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10396274	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113933102	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102480698	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-9787641	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1857593	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1856149	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10126164	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15269	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418957	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	656652	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1778855	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	415816	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1235647	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2274448	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-400547	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-816690	usd
	us-gaap	Gross Profit GrossProfit	-1617796	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2432413	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2761523	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5294307	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-3142769	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2432413	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2761523	usd
	us-gaap	Operating Expenses OperatingExpenses	8437076	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2832960	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3578213	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10054872	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6834727	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1766	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	430173	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	585417	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1399721	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	521	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1747	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	423	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-429652	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-587164	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1397532	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3262612	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4165377	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11452404	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9596	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3262612	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4165377	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11452404	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65435733	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11589937	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11589937	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52526379	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52526379	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7358006	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7358006	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-6752554	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	97500	usd
CY2024Q3	CANB	Stock Issued During Period Value Issuance Of Common Stock In Lieu Of Note Repayments StockIssuedDuringPeriodValueIssuanceOfCommonStockInLieuOfNoteRepayments	130025	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-3262612	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-9787641	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	554887	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	321887	usd
CY2023Q3	CANB	Stock Issued During Period Value Purchase Of Inventory StockIssuedDuringPeriodValuePurchaseOfInventory	175500	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7792	usd
CY2023Q3	CANB	Stock Issued During Period Value Issuance Of Common Stock In Lieu Of Note Repayments StockIssuedDuringPeriodValueIssuanceOfCommonStockInLieuOfNoteRepayments	1029942	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	589216	usd
CY2023Q3	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	254090	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1451665	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4165377	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	219602	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1857593	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	584928	usd
	CANB	Stock Issuance Of Common Stock For Note Repayments StockIssuanceOfCommonStockForNoteRepayments	1094789	usd
	CANB	Stock Issued During Period Value Contract Settlement StockIssuedDuringPeriodValueContractSettlement	579000	usd
	CANB	Stock Issuance Of Common Stock With Note Extension Value StockIssuanceOfCommonStockWithNoteExtensionValue	3000	usd
	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	97003	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1163636	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11452404	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-9787641	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2697925	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2697925	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	917694	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	46875	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	937787	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	589216	usd
	CANB	Stock Issued During Period Value Purchase Of Inventory StockIssuedDuringPeriodValuePurchaseOfInventory	175500	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7792	usd
	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	296633	usd
	CANB	Stock Issued During Period Value Issuance Of Common Stock In Lieu Of Note Repayments StockIssuedDuringPeriodValueIssuanceOfCommonStockInLieuOfNoteRepayments	1029942	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1451665	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	219602	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	219602	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11452404	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1163636	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1451665	usd
	CANB	Stockbased Wages And Salaries StockbasedWagesAndSalaries	589216	usd
	us-gaap	Depreciation Depreciation	343607	usd
	us-gaap	Depreciation Depreciation	1040915	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	488740	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	522274	usd
	CANB	Contract Settlement ContractSettlement	-579000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	715051	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3142769	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1997560	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	38631	usd
	CANB	Cancellation Of Debt CancellationOfDebt	-110000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1766	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
	CANB	Stockbased Interest Expense StockbasedInterestExpense	97003	usd
	CANB	Stockbased Interest Expense StockbasedInterestExpense	296633	usd
	CANB	Stockbased Consulting Expense StockbasedConsultingExpense	917694	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-305806	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	64960	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1463625	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1239847	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5928	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8115	usd
	CANB	Increase Decrease In Lease Right Of Use Asset IncreaseDecreaseInLeaseRightOfUseAsset	-40760	usd
	CANB	Increase Decrease In Lease Right Of Use Asset IncreaseDecreaseInLeaseRightOfUseAsset	-140	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3416	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1220983	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	733022	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	95026	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1455933	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	10337	usd
	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	70000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10337	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-85000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2255000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	361423	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	630943	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	178000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	100607	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	53000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-110816	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1499057	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26127	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41876	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34006	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	73194	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7879	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31318	usd
	CANB	Issuance Of Common Stock In Lieu Of Repayments Of Notes Payable IssuanceOfCommonStockInLieuOfRepaymentsOfNotesPayable	1094764	usd
	CANB	Issuance Of Common Stock In Lieu Of Repayments Of Notes Payable IssuanceOfCommonStockInLieuOfRepaymentsOfNotesPayable	1029942	usd
	CANB	Issuance Of Common Stock For Contract Settlement IssuanceOfCommonStockForContractSettlement	579000	usd
	CANB	Issuance Of Note Payable In Connection With Note Extension IssuanceOfNotePayableInConnectionWithNoteExtension	250000	usd
	us-gaap	Stock Issued1 StockIssued1	46875	usd
	CANB	Issuance Of Common Stock For Payables IssuanceOfCommonStockForPayables	584928	usd
	CANB	Debt Discount Associated With Convertible Note DebtDiscountAssociatedWithConvertibleNote	273529	usd
	CANB	Issuance Of Common Stock Warrants And Commitment Shares In Connection With Convertible Promissory Note IssuanceOfCommonStockWarrantsAndCommitmentSharesInConnectionWithConvertiblePromissoryNote	937787	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7879	usd
CY2024Q3	CANB	Working Capital WorkingCapital	10049951	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11452404	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113933102	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zJw89vn0p7q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zxl1Hp3Utn25">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, intangible assets and other long-lived assets, income taxes and deferred taxes. Descriptions of these policies are discussed in the Company’s 2023 Form 10-K. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and adjusts when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Notes Payable NotesPayable	803225	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z6q5Gc63PA29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zK2AJMwotuEd">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation. These reclassification adjustments had no effect on the Company’s previously reported net loss. December 2023 revenues and accounts payable were misstated and a correction of $<span id="xdx_907_ecustom--RevenueTransactionCost_c20231231__20231231_z40SmFJeQ6X" title="Revenue transaction cost">52,400</span> was made related to a transaction reversal with a vendor.</span></p>
CY2023Q4	CANB	Revenue Transaction Cost RevenueTransactionCost	52400	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1766	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	203043	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	123625	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1766	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1766	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1766	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	26827	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1196112	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	129090	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	423430	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	155917	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1619542	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21724	usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	12378	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6828083	usd
CY2023Q4	CANB	Medical Equipment MedicalEquipment	776396	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	26902	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7665483	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3559200	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4106283	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	348224	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	343607	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1040915	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3142769	usd
CY2023Q4	CANB	Finite Lived Technology Ip And Patents FiniteLivedTechnologyIpAndPatents	119998	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	119998	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24854	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	95144	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	95144	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1354210	usd
CY2023Q4	CANB	Percentage Of Outstanding Common Stock PercentageOfOutstandingCommonStock	0.0999	pure
CY2022	CANB	Purchase Amount Of Future Receivables PurchaseAmountOfFutureReceivables	450000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	198248	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.24	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12223331	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.08
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	27019284	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.04
	CANB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	39242615	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.99
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1451665	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1163636	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1451665	usd

Files In Submission

Name	View Source	Status
0001493152-24-046837-index-headers.html	Edgar Link	pending
0001493152-24-046837-index.html	Edgar Link	pending
0001493152-24-046837.txt	Edgar Link	pending
0001493152-24-046837-xbrl.zip	Edgar Link	pending
canb-20240930.xsd	Edgar Link	pending
ex10-75.htm	Edgar Link	pending
ex10-76.htm	Edgar Link	pending
ex10-77.htm	Edgar Link	pending
ex10-78.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
canb-20240930_def.xml	Edgar Link	unprocessable
canb-20240930_lab.xml	Edgar Link	unprocessable
canb-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
canb-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CANB
Can B Corp Stock $canb

2024 Q4 Form 10-Q Financial Statement

#000149315224046837 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CANB Can B Corp Stock $canb

2024 Q4 Form 10-Q Financial Statement

#000149315224046837 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CANB
Can B Corp Stock $canb